BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Battered Helicos BioSciences Corporation (HLCS) Files for Chapter 11


11/16/2012 11:17:14 AM

Battered by years of rough financial sledding and tough competition from rival next-generation sequencing companies, Helicos Biosciences filed Thursday for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code. In its filing (Case 12-19091) in U.S. Bankruptcy Court for the District of Massachusetts, Helicos listed $15.478 million in liabilities and only $3.503 million in assets. On the day of its bankruptcy filing, Helicos sent notice to the U.S. Securities and Exchange Commission (SEC) that it would be late in filing third-quarter results. “The Board of Directors of the Company has determined that continued operation of the Company outside of bankruptcy protection is not possible due to its lack of cash resources and no available funding options,” Helicos stated in the notice. The Chapter 11 filing came about three months after Helicos last released quarterly results, which showed the company recording a Q2 loss of $459,000, an improvement over its $1.771 million loss for the second three months of 2011. Another brighter note was its cash and cash equivalents, which rose as of Aug. 9 to $2.1 million from $446,000 at the end of Q2. But Helicos’ second-quarter revenues plunged 29% from a year earlier, to $577,000 from $809,000 in Q2 2011: “The Company does not generate sufficient funds to operate its business. The Company continues to require significant additional capital on a month-to-month basis,” Helicos stated in its 10-Q filing with the SEC. Helicos sought to stem its financial bleeding with rounds of layoffs in 2010 and 2011 that eliminated a combined 66 positions, leaving it with 10 full- and part-time employees at the start of his year, and just eight at the start. While the company has long struggled financially, its troubles mounted in recent months. President and CEO Ivan Trifunovich resigned from those positions Sept. 14, two weeks after he resigned as executive chairman of Helicos' board of directors. Trifunovich served at the helm of Helicos less than two years, taking office in October 2010.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES